Navigation Links
Mindray Medical International Announces First Quarter 2008 Results
Date:5/7/2008

SHENZHEN, China, May 7 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly growing international presence, today announced its selected unaudited financial results for the first quarter ended March 31, 2008.

Highlights for First Quarter 2008

-- First quarter 2008 net revenues were RMB626.0 million (US$89.3 million),

an increase of 48.2% over from RMB422.4 million (US$54.7 million) in

the first quarter 2007.

-- Net revenues generated in international markets in the first quarter

2008 were RMB319.6 million (US$45.6 million), an increase of 49.4% from

RMB213.9 million (US$27.7 million) in the first quarter 2007.

-- Net revenues generated in China in the first quarter 2008 were

RMB306.4 million (US$43.7 million), an increase of 46.9% from RMB208.5

million (US$27.0 million) in the first quarter 2007.

-- Non-GAAP operating profit, as defined below, in the first quarter 2008

was RMB220.5 million (US$31.4 million), a 54.6% increase from RMB142.6

million (US$18.5 million) in the first quarter 2007. First quarter 2008

GAAP operating profit was RMB199.8 million (US$28.5 million).

-- First quarter 2008 non-GAAP net income, as defined below, was RMB199.2

million (US$28.4 million), an increase of 42.7% from RMB139.6 million

(US$18.1 million) in the first quarter 2007. First quarter 2008 GAAP net

income was RMB179.4 million (US$25.6 million).

-- First quarter 2008 non-GAAP diluted earnings per share, as defined

below, was RMB1.76 (US$0.25) compared to RMB1.25 (US$0.16) in t
'/>"/>

SOURCE Mindray Medical International Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
2. Mindray Announces Appointment of Dr. Jixun Lin as Independent Director
3. Mindray Medical International Announces Third Quarter 2007 Results
4. Mindray to Acquire Datascopes Patient Monitoring Business for US$202 million
5. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
6. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
7. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
8. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
9. BioMS Medical announces its intention to renew a normal course issuer bid
10. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
11. ATS Medical Expands Open Pivot Heart Valve Offerings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... for its newly developed Bruton,s tyrosine kinase (BTK) ... completed. The results of these preclinical evaluations have ... Administration. The feedback received from the Agency is ... study. Additional preclinical work is required to begin ...
(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine”) ... company, today announced that the U.S. Food and ... Track designation and Phase I clinical trials of ... the mutual co-development agreement signed with Gilead Life ... designation for the DPX-Survivac. , “We have been ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
(Date:2/27/2015)... BERKELEY, Calif. , Feb. 27, 2015  Steep ... in the US and internationally, intends to open a ... Albuquerque, New Mexico , bringing advanced scientific ... of cannabis. Steep Hill is currently the ... Health to conduct potency and contaminant testing in order ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Steep Hill First to Receive Provisional Approval to Establish Laboratory Services for Cannabis Testing in State of New Mexico 2
... , Overview ... basis of the separation and purification of a number of biological ... for protein A, or a protein may be purified on the ... Typically, these purifications take place in a chromatographic column with a ...
... Purpose , Increased ... LC/MS/MS System for N-in-1 experiments. Patented LINAC collision cell technology plays a ... sensitivity. , Overview , ... LC/MS/MS has made an important impact is in N-in-1 studies (also referred ...
... Abstract , ... and widely used tools in the biological sciences. In ... cytokines in the tissue culture supernatants of treated cells. ... (HTS) because they require cumbersome manipulations. Applied Biosystems has ...
Cached Biology Technology:Use of ZipTip Pipette Tips for Microscale Affinity Mass Spectrometry 2Use of ZipTip Pipette Tips for Microscale Affinity Mass Spectrometry 3Detection of N-in-1 Experiments: Extending the Range of N Using the API 3000 LC/MS/MS System 2Detection of N-in-1 Experiments: Extending the Range of N Using the API 3000 LC/MS/MS System 3Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 2Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 3Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 4Mix-and-Read, Bead- and Cell-Based Immunoassays Using the FMAT 8100 HTS System 5
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
(Date:2/5/2015)... 2015   Epic Sciences , a precision diagnostics company ... Murali Prahalad , Ph.D., president and CEO, is scheduled ... (PMWC) 2015: Silicon Valley, which is taking place at the ... on January 26-28, 2015. Dr. Prahalad ... Biomarkers." Last year, Epic Sciences was a finalist in the ...
(Date:2/5/2015)... , January 28, 2015 ... Analysis, Size And Segment Forecasts To 2020 has Been ... IR camera market is expected to reach USD 5.10 ... Grand View Research, Inc. IR cameras help identify the ... are expected to witness surging demand in medical imaging ...
Breaking Biology News(10 mins):Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... help to raise the offspring of other group members are ... for more distant kin, a new study has found., The ... Australia, the chestnut-crowned babbler, also found that these birds work ... the young of less-related group members., The findings, published in ...
... Elser today received the G. Evelyn Hutchinson Award, the ... the July 2012 Association for the Sciences of Limnology ... Lake Biwa, Otsu, Shiga, Japan. The Hutchinson Award is ... 10 years of excellence in limnology (the study of ...
... CORVALLIS, Ore. Scientists have discovered two viruses that appear ... are important for coral growth and health, and they say ... of coral ecosystems around the world. These viruses, ... have been shown for the first time to clearly be ...
Cached Biology News:Helping family is key for social birds 2ASU ecologist receives prestigious global award for water research 2ASU ecologist receives prestigious global award for water research 3Viruses linked to algae that control coral health 2
Goat polyclonal to STMN2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AKTAMAYKEK, corresponding to C terminal amino acids 2-11 of STMN2. Entrez Gene ID: 11075 Swi...
Mouse monoclonal antibody to RNase L...
Anti (porcine) Vitronectin...
... Rabbit polyclonal to BMP2 BMP2 ... beta (TGFB) superfamily. Bone morphogenic protein ... candidate gene for the autosomal dominant ... Immunogen: Synthetic peptide: ...
Biology Products: